TSPAN17

gene
On this page

Also known as FBX23

Summary

TSPAN17 (tetraspanin 17, HGNC:13594) is a protein-coding gene on chromosome 5q35.2, encoding Tetraspanin-17 (Q96FV3). Part of TspanC8 subgroup, composed of 6 members that interact with the transmembrane metalloprotease ADAM10.

This gene encodes a member of the transmembrane 4 superfamily. It is characterized by four tetraspanin transmembrane segments. The function of this gene has not yet been determined.

Source: NCBI Gene 26262 — RefSeq curated summary.

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 47 total
  • MANE Select transcript: NM_130465

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:13594
Approved symbolTSPAN17
Nametetraspanin 17
Location5q35.2
Locus typegene with protein product
StatusApproved
AliasesFBX23
Ensembl geneENSG00000048140
Ensembl biotypeprotein_coding
OMIM620446
Entrez26262

Gene structure

Transcript identifiers

Ensembl transcripts: 26 — 24 protein_coding, 1 nonsense_mediated_decay, 1 retained_intron

ENST00000298564, ENST00000310032, ENST00000503030, ENST00000503045, ENST00000504168, ENST00000507471, ENST00000508164, ENST00000514705, ENST00000515708, ENST00000860608, ENST00000860609, ENST00000860610, ENST00000860611, ENST00000860612, ENST00000860613, ENST00000860614, ENST00000917608, ENST00000917609, ENST00000917610, ENST00000917611, ENST00000917612, ENST00000917613, ENST00000917614, ENST00000917615, ENST00000956721, ENST00000956722

RefSeq mRNA: 5 — MANE Select: NM_130465 NM_001006616, NM_001366491, NM_001366492, NM_012171, NM_130465

CCDS: CCDS34298, CCDS47346, CCDS54952

Canonical transcript exons

ENST00000508164 — 9 exons

ExonStartEnd
ENSE00001219135176654895176655020
ENSE00001716853176647484176647702
ENSE00002036859176657518176659051
ENSE00003484462176652743176652913
ENSE00003494752176651616176651666
ENSE00003517507176656700176656816
ENSE00003518006176651754176651900
ENSE00003667839176656078176656125
ENSE00003785372176656895176656956

Expression profiles

Bgee: expression breadth ubiquitous, 250 present calls, max score 92.84.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 22.2253 / max 253.2741, expressed in 1800 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
6043220.95341799
604311.2719949

Top tissues by expression

258 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
right adrenal glandUBERON:000123392.84gold quality
right adrenal gland cortexUBERON:003582792.77gold quality
pancreatic ductal cellCL:000207992.38gold quality
left adrenal glandUBERON:000123492.34gold quality
left adrenal gland cortexUBERON:003582592.24gold quality
adrenal cortexUBERON:000123592.12gold quality
cerebellar vermisUBERON:000472091.49gold quality
adrenal glandUBERON:000236991.45gold quality
granulocyteCL:000009491.24gold quality
upper arm skinUBERON:000426390.98silver quality
ileal mucosaUBERON:000033190.89gold quality
apex of heartUBERON:000209890.73gold quality
gastrocnemiusUBERON:000138890.65gold quality
stromal cell of endometriumCL:000225590.64gold quality
tibialis anteriorUBERON:000138590.38silver quality
muscle of legUBERON:000138390.12gold quality
lower esophagus mucosaUBERON:003583489.93gold quality
prefrontal cortexUBERON:000045189.67gold quality
nasal cavity epitheliumUBERON:000538489.62silver quality
left ventricle myocardiumUBERON:000656689.49silver quality
mucosa of transverse colonUBERON:000499189.32gold quality
adrenal tissueUBERON:001830389.32gold quality
right frontal lobeUBERON:000281089.06gold quality
heart left ventricleUBERON:000208488.87gold quality
hindlimb stylopod muscleUBERON:000425288.76gold quality
cardiac ventricleUBERON:000208288.60gold quality
adenohypophysisUBERON:000219688.52gold quality
anterior cingulate cortexUBERON:000983588.40gold quality
kidney epitheliumUBERON:000481988.35silver quality
metanephros cortexUBERON:001053388.35gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes3.07

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

54 targeting TSPAN17, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-118499.9968.191458
HSA-MIR-426799.9666.532368
HSA-MIR-450B-5P99.9271.483175
HSA-MIR-3934-3P99.7665.511351
HSA-MIR-6764-5P99.7567.892304
HSA-MIR-472999.6972.184233
HSA-MIR-3158-5P99.6567.511763
HSA-MIR-10394-5P99.6566.831852
HSA-MIR-6848-3P99.6466.49885
HSA-MIR-4743-3P99.6268.122095
HSA-MIR-497-3P99.6169.711990
HSA-MIR-24-3P99.5969.971934
HSA-MIR-1915-3P99.5866.791988
HSA-MIR-4687-3P99.4866.41968
HSA-MIR-766-3P99.4765.241811
HSA-MIR-608099.4369.43373
HSA-MIR-425199.4069.193363
HSA-MIR-6843-3P99.2666.42915
HSA-MIR-422A99.1865.83550
HSA-MIR-6815-3P99.1368.981530
HSA-MIR-6830-5P99.0168.731884
HSA-MIR-570198.9769.541502
HSA-MIR-520G-3P98.9167.381914
HSA-MIR-520H98.9167.381914
HSA-MIR-76098.8166.651392
HSA-MIR-6840-3P98.6865.951923
HSA-MIR-1227-5P98.6565.321549
HSA-MIR-4680-3P98.6468.602093
HSA-MIR-4726-3P98.4963.891385
HSA-MIR-378A-3P98.4366.10548

Literature-anchored findings (GeneRIF, showing 2)

  • Endothelial Tspan5- and Tspan17-ADAM10 complexes may regulate inflammation by maintaining normal VE-cadherin expression and promoting T lymphocyte transmigration. (PMID:28600292)
  • Data suggested that increased miR378a3p and decreased TSPAN17 levels were associated with improved survival in glioblastoma multiforme (GBM). Additionally, high levels of TSPAN17 were linked to the poor prognosis of patients with GBM aged 5060, larger tumor sizes and an advanced World Health Organization stage. TSPAN17 was identified and confirmed as a direct target of miR378a. (PMID:31432186)

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_reriotspan17ENSDARG00000114067
mus_musculusTspan17ENSMUSG00000025875
rattus_norvegicusTspan17ENSRNOG00000018122

Paralogs (32): TSPAN6 (ENSG00000000003), CD9 (ENSG00000010278), TSPAN9 (ENSG00000011105), TSPAN32 (ENSG00000064201), CD82 (ENSG00000085117), TSPAN15 (ENSG00000099282), CD37 (ENSG00000104894), UPK1A (ENSG00000105668), TSPAN12 (ENSG00000106025), TSPAN13 (ENSG00000106537), TSPAN14 (ENSG00000108219), CD81 (ENSG00000110651), TSPAN11 (ENSG00000110900), PRPH2 (ENSG00000112619), UPK1B (ENSG00000114638), TSPAN1 (ENSG00000117472), TSPAN8 (ENSG00000127324), TSPAN16 (ENSG00000130167), TSPAN2 (ENSG00000134198), CD63 (ENSG00000135404), TSPAN31 (ENSG00000135452), TSPAN3 (ENSG00000140391), CD53 (ENSG00000143119), ROM1 (ENSG00000149489), TSPAN7 (ENSG00000156298), TSPAN18 (ENSG00000157570), TSPAN33 (ENSG00000158457), TSPAN5 (ENSG00000168785), CD151 (ENSG00000177697), TSPAN10 (ENSG00000182612), TSPAN4 (ENSG00000214063), TSPAN19 (ENSG00000231738)

Protein

Protein identifiers

Tetraspanin-17Q96FV3 (reviewed: Q96FV3)

Alternative names: F-box only protein 23, Tetraspan protein SB134, Transmembrane 4 superfamily member 17

All UniProt accessions (6): Q96FV3, D6RBW9, D6RDX8, D6RI03, H0Y9A5, J3KNG2

UniProt curated annotations — full annotation on UniProt →

Function. Part of TspanC8 subgroup, composed of 6 members that interact with the transmembrane metalloprotease ADAM10. This interaction is required for ADAM10 exit from the endoplasmic reticulum and for enzymatic maturation and trafficking to the cell surface as well as substrate specificity. Different TspanC8/ADAM10 complexes have distinct substrates. Seems to regulate VE-cadherin expression in endothelial cells probably through interaction with ADAM10, promoting leukocyte transmigration.

Subunit / interactions. Interacts with ADAM10; the interaction influences ADAM10 substrate specificity, endocytosis and turnover.

Subcellular location. Cell membrane.

Similarity. Belongs to the tetraspanin (TM4SF) family.

Isoforms (4)

UniProt IDNamesCanonical?
Q96FV3-11yes
Q96FV3-32
Q96FV3-23
Q96FV3-44

RefSeq proteins (5): NP_001006617, NP_001353420, NP_001353421, NP_036303, NP_569732* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR000301Tetraspanin_animalsFamily
IPR008952Tetraspanin_EC2_sfHomologous_superfamily
IPR018499Tetraspanin/PeripherinFamily
IPR018503Tetraspanin_CSConserved_site

Pfam: PF00335

UniProt features (23 total): topological domain 5, splice variant 5, disulfide bond 4, transmembrane region 4, glycosylation site 2, chain 1, sequence variant 1, sequence conflict 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q96FV3-F188.480.72

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Disulfide bonds (4): 155–223, 156–188, 172–182, 189–202

Glycosylation sites (2): 51, 171

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 116 (showing top): GOBP_MACROMOLECULE_CATABOLIC_PROCESS, IVANOVA_HEMATOPOIESIS_MATURE_CELL, GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_ORGANELLE, GGGTGGRR_PAX4_03, CATRRAGC_UNKNOWN, MCBRYAN_PUBERTAL_BREAST_4_5WK_DN, GOBP_REGULATION_OF_CATABOLIC_PROCESS, AML_Q6, HFH8_01, TCF11_01, FOXJ2_01, HFH4_01, GOBP_REGULATION_OF_MEMBRANE_PROTEIN_ECTODOMAIN_PROTEOLYSIS, HFH3_01, GOBP_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS

GO Biological Process (3): intracellular protein localization (GO:0008104), regulation of membrane protein ectodomain proteolysis (GO:0051043), establishment of protein localization to organelle (GO:0072594)

GO Molecular Function (1): enzyme binding (GO:0019899)

GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
macromolecule localization1
membrane protein ectodomain proteolysis1
regulation of proteolysis1
regulation of protein catabolic process1
establishment of protein localization1
protein binding1
membrane1
cell periphery1
cellular anatomical structure1

Protein interactions and networks

STRING

880 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
TSPAN17ADAM10O14672759
TSPAN17TSPAN31Q12999666
TSPAN17TSPAN13O95857578
TSPAN17TSPAN12O95859493
TSPAN17CSNK1A1P48729491
TSPAN17TSPAN16Q9UKR8392
TSPAN17ZNF727A8MUV8380
TSPAN17CFAP68Q9H5F2370
TSPAN17SCG5P01164363
TSPAN17TSPAN32Q96QS1349
TSPAN17TSPAN1O60635338
TSPAN17ADAM17P78536338
TSPAN17CDH17Q12864321
TSPAN17FBXO34Q9NWN3318
TSPAN17FAM43BQ6ZT52317

IntAct

8 interactions, top by confidence:

ABTypeScore
TSPAN17UPK3BL1psi-mi:“MI:0914”(association)0.530
ADAM10TSPAN17psi-mi:“MI:0915”(physical association)0.400
TSPAN17MGST3psi-mi:“MI:0914”(association)0.350
TSPAN17HACD3psi-mi:“MI:0915”(physical association)0.000
TSPAN17UBA1psi-mi:“MI:0220”(ubiquitination reaction)0.000

BioGRID (119): TSPAN17 (Affinity Capture-RNA), ADAM10 (Affinity Capture-Western), ATP2A3 (Affinity Capture-MS), PNPLA6 (Affinity Capture-MS), DGKE (Affinity Capture-MS), TBL2 (Affinity Capture-MS), RETSAT (Affinity Capture-MS), DHRS7 (Affinity Capture-MS), TYW1 (Affinity Capture-MS), GHDC (Affinity Capture-MS), AGPAT4 (Affinity Capture-MS), SLC44A1 (Affinity Capture-MS), AGPAT3 (Affinity Capture-MS), ACVR1B (Affinity Capture-MS), CYP51A1 (Affinity Capture-MS)

ESM2 similar proteins: O43657, O46101, O60635, O70352, O70401, O97703, P08962, P19075, P19331, P19397, P24485, P27591, P27701, P28648, P35762, P40237, P41731, P41732, P60033, P60034, P62079, P62080, Q17QJ5, Q26499, Q28709, Q2KIS9, Q32KU6, Q3T0S3, Q3ZCD0, Q4R7W6, Q4V8E0, Q58DM3, Q58DN3, Q5R9S6, Q5RAS5, Q5RC27, Q61451, Q62283, Q62745, Q68VK5

Diamond homologs: A1L157, B5X3I6, O14817, O35566, O60636, O70352, P19075, P24485, P27701, P40241, P48509, P60033, P60034, P61170, P61171, Q0VC33, Q3ZBH3, Q4V8E0, Q568Y5, Q58CY8, Q58DN3, Q5R9S6, Q5RAP3, Q61451, Q80WR1, Q8WMQ3, Q96FV3, Q96SJ8, Q9D1D1, Q9D7W4, Q9DCK3, Q9JJW1, Q9QZA6, F7BWT7, O95858, P62079, P62080, Q17QJ5, Q1JQA4, Q3SYV5

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

47 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance29
Likely benign2
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1549 predictions. Top by Δscore:

VariantEffectΔscore
5:176647700:TGGG:Tdonor_loss1.0000
5:176647701:GG:Gdonor_gain1.0000
5:176647702:GG:Gdonor_gain1.0000
5:176647702:GGT:Gdonor_loss1.0000
5:176647703:G:GGdonor_gain1.0000
5:176647704:T:Adonor_loss1.0000
5:176651897:GTTT:Gdonor_gain1.0000
5:176651901:G:GGdonor_gain1.0000
5:176652757:C:Aacceptor_gain1.0000
5:176652908:GAA:Gdonor_gain1.0000
5:176652914:G:GGdonor_gain1.0000
5:176654891:ACAGT:Aacceptor_gain1.0000
5:176654892:CAG:Cacceptor_loss1.0000
5:176654893:A:AGacceptor_gain1.0000
5:176654893:A:ATacceptor_loss1.0000
5:176654893:AGT:Aacceptor_gain1.0000
5:176654893:AGTG:Aacceptor_gain1.0000
5:176654894:G:GTacceptor_gain1.0000
5:176654894:GT:Gacceptor_gain1.0000
5:176654894:GTG:Gacceptor_gain1.0000
5:176654894:GTGG:Gacceptor_gain1.0000
5:176654894:GTGGT:Gacceptor_gain1.0000
5:176656076:AGGAG:Aacceptor_gain1.0000
5:176656077:GGAGG:Gacceptor_gain1.0000
5:176656122:ACTGG:Adonor_loss1.0000
5:176656126:G:GGdonor_gain1.0000
5:176656127:T:Gdonor_loss1.0000
5:176656132:GGG:Gdonor_gain1.0000
5:176656133:GGG:Gdonor_gain1.0000
5:176656697:CAG:Cacceptor_loss1.0000

AlphaMissense

2168 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1000153661 (5:176648525 C>T), RS1000214522 (5:176653799 T>C), RS1000275022 (5:176651335 A>G), RS1000401913 (5:176646544 C>T), RS1000486767 (5:176659273 C>T), RS1000756279 (5:176659089 C>T), RS1000770271 (5:176656982 C>T), RS1001076636 (5:176657152 T>C), RS1001402098 (5:176654677 G>A), RS1001686584 (5:176647466 G>A,C), RS1001947858 (5:176649899 A>C,G), RS1002176958 (5:176651377 G>A), RS1002207935 (5:176651105 G>A), RS1002303937 (5:176650170 G>A), RS1002592874 (5:176647773 G>A)

Disease associations

OMIM: gene MIM:620446 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST009921_4Carotid intima media thickness (mean)3.000000e-12

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

22 total (human), top 22 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Acidaffects expression, increases methylation2
aristolochic acid Iincreases expression1
bufotalindecreases expression1
beta-lapachonedecreases expression1
sodium arseniteincreases abundance, decreases expression1
nickel sulfateincreases expression1
di-n-butylphosphoric acidaffects expression1
perfluorooctane sulfonic aciddecreases expression1
ICG 001increases expression1
jinfukangincreases expression1
4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acidincreases expression1
Sunitinibincreases expression1
Leflunomidedecreases expression1
Acetaminophendecreases expression1
Arsenicdecreases expression, increases abundance1
Cisplatinincreases expression1
Doxorubicindecreases expression1
Phthalic Acidsincreases methylation1
Smokedecreases expression1
Tobacco Smoke Pollutionincreases expression1
Okadaic Acidincreases expression1
Acrylamidedecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.